Alpine Global Management, LLC Aldeyra Therapeutics, Inc. Transaction History

Alpine Global Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$3.8 - $7.74 $45,695 - $93,073	12,025 New	12,025 $64,000
Q1 2022 May 13, 2022	SELL	$3.25 - $5.17 $34,391 - $54,708	-10,582 Reduced 46.81%	12,025 $53,000
Q4 2021 Feb 14, 2022	BUY	$3.5 - $9.63 $79,124 - $217,705	22,607 New	22,607 $90,000
Q1 2021 May 13, 2021	SELL	$6.53 - $14.42 $182,010 - $401,928	-27,873 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$6.31 - $8.13 $175,878 - $226,607	27,873 New	27,873 $191,000

116

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $298M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.